You are here: Industry Insights > Pfizer

News List

Norway raises concern about Pfizer Covid-19 vaccine safety after 29 deaths pharmaceutical-technology
January 19, 2021
Norway has raised concerns about Pfizer’s Covid-19 vaccine safety after 29 elderly people with serious underlying health conditions have died after receiving the shot.
Pfizer gets USFDA nod for XALKORI (crizotinib) to treat ALK-positive ALCL in children and young adults expresspharma
January 15, 2021
XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people.
Pfizer Appoints President of AfME Region contractpharma
January 13, 2021
Pfizer has appointed Patrick van der Loo as Regional President for Africa and the Middle East (AfME) region. Patrick has more than 20 years of experience at Pfizer in leadership roles across multiple geographies.
$30 bn sales forecast for Pfizer-BioNTech COVID-19 vaccine from 2020-2026: GlobalData expresspharma
January 12, 2021
The main challenge for BNT-162b2 is the ultra-cold storage requirement of -80°C. The vaccine is likely to suffer poor uptake in countries that have limited cold-chain logistics.
An in vitro study shows Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with a mutation associated with rapid transmission worldpharmanews
January 11, 2021
Pfizer Inc. and BioNTech SE announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively ...
Study suggests Pfizer/BioNTech vaccine effective against Covid-19 variants pharmaceutical-technology
January 11, 2021
New research suggests that Pfizer/BioNTech’s mRNA Covid-19 vaccine, BNT162b2, protects against two variants of SARS-CoV-2, the virus that causes Covid-19, that have emerged in the UK and South Africa.
Drug pricing, reimbursement constraints leading impediments to industry growth in 2021: GlobalData expresspharma
January 11, 2021
In 2021, drug pricing pressure from regulators and payers will remain and aggressive negotiation tactics to drive down drug prices will continue, according to GlobalData, a data and analytics company.
Colombia grants emergency use approval for Pfizer-BioNTech Covid-19 vaccine pharmaceutical-technology
January 07, 2021
Colombia’s National Institute of Drug and Food Surveillance (INVIMA) has authorised emergency use of Pfizer and BioNTech’s Covid-19 vaccine.
COVID-19 vaccine key conversation driver for Pfizer among Twitter influencers during Q4 2020– GlobalData expresspharma
January 07, 2021
The Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK and the US Food and Drug Administration (FDA) authorised Pfizer and BioNTech’s mRNA vaccine (BNT162b2) for emergency use against COVID-19 in December 2020.
Germany says does not intend to delay second COVID-19 vaccine shot expresspharma
January 07, 2021
Germany intends to stick to recommendations by BioNTech and Pfizer regarding the administration of a second dose of their COVID-19 vaccines rather than delaying it, Health Minister Jens Spahn said on Wednesday.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page